Literature DB >> 8799877

A high-performance liquid-chromatographic microanalytical procedure for the rapid estimation of piracetam in plasma or cerebrospinal fluid.

M H Doheny1, M T O'Connell, P N Patsalos.   

Abstract

Presently available GC and HPLC methods for analysis of piracetam, require large samples and suffer from interference. A micro scale, isocratic high-performance liquid-chromatographic method is described for the determination of piracetam in plasma (25 microL) or cerebrospinal fluid (10 microL) using ultraviolet absorbance at 215 nm. The limit of quantitation is 4 micrograms mL-1 and the within-batch and between-batch coefficients of variation are less than 10%. No interference from other commonly prescribed antimyoclonic or antiepileptic drugs was observed and thus the method can be used to monitor piracetam in patients on polytherapy antimyoclonic or antiepileptic drug regimens. Because of the sensitivity and rapidity of the method it is suitable for pharmacokinetic and mechanistic studies and for analysis of paediatric samples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799877     DOI: 10.1111/j.2042-7158.1996.tb05964.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.

Authors:  Pankaj Paliwal; Debabrata Dash; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Development of new method for simultaneous analysis of piracetam and levetiracetam in pharmaceuticals and biological fluids: application in stability studies.

Authors:  Farhan Ahmed Siddiqui; Nawab Sher; Nighat Shafi; Alisha Wafa Sial; Mansoor Ahmad; Huma Naseem
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

Review 3.  New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).

Authors:  Karina Sommerfeld-Klatta; Barbara Zielińska-Psuja; Marta Karaźniewcz-Łada; Franciszek K Główka
Journal:  Molecules       Date:  2020-11-02       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.